Why is Syncom Formulations (India) Ltd ?
1
Company has a Debt to Equity ratio (avg) of 0.02 times
2
Poor long term growth as Net Sales has grown by an annual rate of -53.39% and Operating profit at -42.14% over the last 5 years
3
Positive results in Jan 70
4
With ROE of 18.4, it has a Expensive valuation with a 4.5 Price to Book Value
- The stock is trading at a premium compared to its peers' average historical valuations
- Over the past year, while the stock has generated a return of 32.85%, its profits have risen by 48.7% ; the PEG ratio of the company is 0.5
5
Despite the size of the company, domestic mutual funds hold only 0% of the company
- Domestic mutual funds have capability to do in-depth on-the-ground research on companies- their small stake may signify either they are not comfortable at the price or the business
6
Market Beating performance in long term as well as near term
- Along with generating 32.85% returns in the last 1 year, the stock has outperformed BSE500 in the last 3 years, 1 year and 3 months
How much should you hold?
- Overall Portfolio exposure to Syncom Formul. should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Syncom Formul. for you?
High Risk, High Return
Absolute
Risk Adjusted
Volatility
Syncom Formul.
32.85%
0.79
41.80%
Sensex
-9.52%
-0.70
13.59%
Quality key factors
Factor
Value
Sales Growth (5y)
-53.39%
EBIT Growth (5y)
-42.14%
EBIT to Interest (avg)
30.08
Debt to EBITDA (avg)
0.72
Net Debt to Equity (avg)
-0.27
Sales to Capital Employed (avg)
9.88
Tax Ratio
24.37%
Dividend Payout Ratio
12.30%
Pledged Shares
0
Institutional Holding
0.35%
ROCE (avg)
80.28%
ROE (avg)
119.22%
Valuation Key Factors 
Factor
Value
P/E Ratio
22
Industry P/E
38
Price to Book Value
4.54
EV to EBIT
21.87
EV to EBITDA
20.19
EV to Capital Employed
5.84
EV to Sales
3.56
PEG Ratio
0.45
Dividend Yield
0.50%
ROCE (Latest)
23.35%
ROE (Latest)
18.41%
Loading Valuation Snapshot...
Technical key factors
Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Bearish
Dow Theory
Mildly Bearish
Mildly Bullish
OBV
Mildly Bearish
Bullish
Technical Movement
Footer loading






